Added to YB: 2026-03-04
Pitch date: 2026-03-01
1681.HK [neutral]
Consun Pharmaceutical Group Limited
-2.37%
current return
Author Info
Momentum Financial researches stocks from around the world to invest in for the long-term. Sign up for the newsletter.
Company Info
Consun Pharmaceutical Group Limited researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
Market Cap
HKD 13.3B
Pitch Price
HKD 17.31
Price Target
N/A
Dividend
3.67%
EV/EBITDA
8.67
P/E
13.40
EV/Sales
3.00
Sector
Pharmaceuticals
Category
growth
Company monitoring. - Consun Pharmaceutical Group Limited
1681.HK (update): Consun partnered with Sun Yat-sen University Hospital for Baihua Zilian granules (lupus nephritis TCM treatment). CNY 20M tech transfer deal—record for hospital. Formula shows improved efficacy vs Western meds alone, reduces relapses/side effects. Holds multiple patents, passed regulatory eval Aug '24. Joint phase II/III trials & commercialization planned. Model demonstrates production-research-application integration in TCM sector.
Read full article (2 min)